Liz KaneImpactful Strategy
Frank BurrellScientific Storytelling
Matt TurnerPatient Affordability
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Paul TheisenPatient Acquisition
Matthew DurhamOmnidynamic Marketing
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Daniel SontupeMarket Access
Amy GilesIncreasing Engagement
WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the ...
– 91% CR+CRi/CRp Rate in Ivosidenib-treated Patients with De Novo AML and 53% in Ivosidenib-treated ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email